SAN FRANCISCO (MarketWatch) -- Possis Medical Inc. said Monday it has received marketing approval from the Food and Drug Administration for its AngioJet Ultra Thrombectomy System, the next-generation ...

Intravenous thrombolysis is the treatment of choice in patients presenting with high- and intermediate-risk pulmonary embolism. The role of percutaneous mechanical pulmonary thrombectomy (PMPT) is not ...

The mechanism in the AngioJet rheolytic thrombectomy (RT) system (Figure 1) involves the delivery of pressurized heparinized saline from the catheter, where saline jets travel backwards creating a low ...

Although the use of primary angioplasty in the acute myocardial infarction (AMI) setting has been shown to achieve TIMI 3 flow in the majority of patients, there are still some instances in which ...

EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies, today announced successful early clinical use of the ...

The Pounce™ Thrombectomy Platform can now be used to remove clot from peripheral arteries as small as 2mm up to as large as 10 mm in diameter, broadening the platform's clinical utility and ...